Trials / Completed
CompletedNCT06671821
Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects
HRS-7535-202 Follow-up Study: A Long-term Evaluation of Safety, Tolerability, and Efficacy in Obese Subjects (Open-label, Extension Trial)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- Shandong Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The Objective of this trial is to evaluate the long-term safety, tolerability, weight loss efficacy and metabolic benefits of HRS-7535 tablets inobesity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-7535 | HRS-7535 |
Timeline
- Start date
- 2024-11-20
- Primary completion
- 2025-08-15
- Completion
- 2025-09-28
- First posted
- 2024-11-04
- Last updated
- 2025-11-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06671821. Inclusion in this directory is not an endorsement.